The landscape of metabolic healthcare, weight management, and advanced cellular research has experienced a massive paradigm shift. Driven by breakthroughs in dual-acting analog therapies, molecules that mimic natural gastric hormones have become the gold standard for clinical and experimental applications. Among these highly discussed compounds, tirzepatide stands out as a dominant dual glucose-dependent insulinotropic polypeptide […]